Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01745016 · ClinicalTrials.gov registry record · NA

Effect of Beta-Alanine on Heart Rate Response

A NA study of Fatigue and Exercise, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT01745016: Completed NA study of Fatigue and Exercise, sponsored by University of North Carolina, Chapel Hill.

NCT01745016 is a NA study of Fatigue and Exercise that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 35 participants, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01745016, a NA study of Fatigue and Exercise, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

Beta-alanine, as a method to increase muscle carnosine, has been shown to enhance muscle buffering capacity and delay fatigue. Various fatigue tests have been utilized to examine the effectiveness of beta-alanine supplementation. The physical working capacity test has been used to show significant increases in physical working capacities following supplementation. The physical working capacity tests were originally developed by Moritani et al. 1981 and Devries et al. 1982 to measure the point of onset of muscular fatigue. It is hypothesized that beta-alanine will increase physical working capacity at heart rate threshold, thereby signifying a delay in fatigue.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Beta-alanine

Study Locations (1)

North Carolina

  • UNC Exercise and Sport Science - Chapel Hill

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2013-01
Est. Completion 2013-04
Phase NA

What the finished NCT01745016 record still lists

NCT01745016 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (84% lower).

The record links to 2 conditions, with Fatigue appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01745016 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT01745016 about?

NCT01745016 is a clinical study titled "Effect of Beta-Alanine on Heart Rate Response". Beta-alanine, as a method to increase muscle carnosine, has been shown to enhance muscle buffering capacity and delay fatigue. Various fatigue tests have been utilized to examine the effectiveness of beta-alanine supplementation. The physical working capacity test has been used to show significant i...

What is the current status of trial NCT01745016?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2013-01. Estimated completion is 2013-04.

What conditions does trial NCT01745016 study?

This clinical trial studies the following conditions: Fatigue, Exercise.

What interventions are being tested in trial NCT01745016?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Beta-alanine (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01745016?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01745016 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fatigue

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01745016's enrollment target sits among peer trials

35 79th of 109 higher than 30 of 109 other Fatigue trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Fatigue trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01745016, the US trial registry maintained by the National Library of Medicine. NCT01745016 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.